Abstract
The diagnostics of community-acquired acute HCVhepatitis in an endemic area was studied in 110 Egyptianpatients with acute jaundice. In the first week of thejaundiced period 30 of 110 patients (27.3%) had anti-HCVantibodies. The majority already showed high levels ofanti-HCV IgG (25/30), associated with anti-HCV IgM innine of them. Five patients showed only an HCV IgMreactivity. Seven had also anti-HEV and/or anti-HBV: their jaundice couldthen be related to an acute infection caused by thoseviruses. All patients were infected with genotype 4a, inthree associated with the 3a. During the follow-up five patients seroconverted for IgG, whiletheir anti-HCV IgM did not show a uniform pattern ofreactivity. Patients with positive serology suspected ofan acute HCV infection were older than the patients with other acute hepatitis and showed a lowerpeak of ALT level. Seroconversion during acute hepatitisstrongly indicated HCV as the etiologic agent. However,the detection of anti-HCV IgG antibodies in the jaundiced period showed that the majorityof patients had already seroconverted to anti-HCVantibodies; in most of them it is possible tohypothesize a reactivation of a chronic HCVinfection.
Similar content being viewed by others
REFERENCES
Francois M, Dubois F, Brand D, Baco Y, Guerois C, Mouchet C, Tichet J, Goudeau A, Barin F: Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations. J Clin Microbiol 31:1189-1192, 1993
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood borne non-A non-B viral hepatitis genome. Science 359-362, 1989
Gretch DR, dela Rosa C, Carithers RL, Willson RA, Williams B, Corey L: Assessment of hepatitis c viremia using molecular amplification technologies: correlations and clinical implications. Ann Intern Med 123:321-329, 1995
Tedeschi V, Seeff LB: Diagnostic tests for hepatitis C: where are we now? Ann Intern Med 123:383-385, 1995
Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G: Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A non-B hepatitis. N Engl J Med 321:1494-1500, 1989
Esteban JI, Gonzales A, Hernandez JM, Viladomiou L, Sanchez C, Lopez-Talavera JC, Lucead, Matin-Vega C, Vidal X, Esteban R, Guardia J: Evaluation of antibodies to hepatitis C virus in a study of transfusion associated hepatitis. N Engl J Med 332:1107-1112, 1990
Peters T, Mohr L, Scheiffele F, Schlayer HJ, Preisler S, Berthold H, Gerok W, Rasenack J: Antibodies and viremia in acute post-transfusion hepatitis C: A prospective study. J Med Virol 42:420-427, 1990
Hino K, Sainokami S, Shimoda K, Niwa H, Iimo S: Clinical course of acute hepatitis C and changes in HCV markers. Dig Dis Sci 39:19-27, 1994
Chen DS, Kuo GC, Sung JL, Lai MY, Sheu JC, Chen PJ, Yang PM, Hsu HM, Chang MH, Chen CJ, Hahn LC, Choo QL, Wang TH, Houghton M: Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: The Taiwan experience. J Infect Dis 162:817-882, 1990
Kiyosawa K, Tanaka E, Sodeyama T, Yoshizawa K, Yabu K, Furuta K, Imai H, Nakano Y, Usuda S, Uemura K: Transmission of hepatitis C in an isolated area in Japan: Community-acquired infection. The south Kiso hepatitis study group. Gastroenterology 106:1596-1602, 1994
Kamel MA, Ghaffar YA, Wasef MA, Wright M, Clark LC, Miller F: High HCV prevalence in Egyptian blood donors. Lancet 340:427, 1992
Arthur RR, Imam IZ, Saad MD, Hackbart BG, Mossad SB: HCV in Egypt in 1977. Lancet 346:1239-1240, 1995
Waked IA, Saleh SM, Mustafa MS, Raouf AA, Thomas DL, Strickland GT: High prevalenca of hepatitis C in Egyptian patients with chronic liver disease. Gut 37:105-107, 1995
Quinti I, Hassan NF, Salman DE, Shalaby H, Zimatty DE, Monier MK, Arthur RR: Hepatitis C virus=specific B cell activation: IgG and IgM detection in acute and chronic hepatitis C. J Hepatol 23:640-647, 1995
Gomatos PJ, Monier MK, Arthur RR, Rodier GR, Hackbart BJ, Saad MD, Zimatty DE, Hyams CK, Osman S, Hassan NF, Quinti I, Sahly ADE, Emara K, Sultan Y, Imam IZ: The etiology of community acquired viral hepatitis in Cairo, Egypt. Diagnosis of HEV infection. Infect Immun (in press)
Dawson GJ, Chau KH, Cabal CM, Yarbourgh PO, Reyes GR, Mushahwar IK: Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J Virol Methods 38:175-186, 1992
Buch J, Purcell RH, Miller RH: Importance of primer selection for the detection of hepatitis C RNA with the polymerase chain reaction assay. Proc Natl Acad Sci USA 89:187-191, 1992
Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverawyn H, Maertens G: Typing of HCV isolates and characterization of new subtypes using a line probe assay. J Gen Virol 74:1093-1102, 1993
Yamaguchi K, Tanaka E, Higashi K, Kiyosawa K, Mastumoto A, Furuta S, Hasegawa A, Tanaka S, Kohara M: Adaptation of hepatitis C virus for persitent infection in patients with acute hepatitis. Gastroenterology 106:1344-1348, 1994
Hosoda K, Omata M, Yokosuka O, Kato N, Ohto M: Non-A non-B chronic hepatitis is chronic hepatitis C: A sensitive assay for detection of hepatitis C virus RNA in the liver. Hepatology 15:777-781, 1992
Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, Purcell RH: A long-term study of hepatitis C virus replication in non-A non-B hepatitis. N Engl J Med 325:98-104, 1991
Wang JT, Wang TH, Sheu JC, Lin JT, Wang CY, Chen DS: Posttransfusion hepatitis revisited by hepatitis C antibody assays and polymerase chain reaction. Gastroenterology 103:609-616, 1992
Ohkawa K, Hayashi N, Yuki N, Hagiwara H, Kato M, Yamamoto K, Eguchi H, Fusamoto H, Masuzawa M, Kamada T: Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients. J Hepatol 21:509-514, 1994
Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ: The natural history of community acquired hepatitis C in the United States. N Engl J Med 327:1899-1905, 1992
Krogsgaard K, Wantzin P, Mathiesen LR, Sonne J, Ring-Larsen H: Early appearance of antibodies to hepatitis C virus in community acquired acute non-A non-B hepatitis is associated with progression to chronic liver disease. Scand J Infect Dis 22:399-402, 1990
Quinti I, Renganathan E, Gazzawi EE, Divizia M, Sawaf G, Awad S, Pana A, Rocchi G: Seroprevalence of HIV and HCV infections in Alexandria, Egypt. Zentralbl Bakteriol 283:239-244, 1995
Garson JA, Tuke PW, Makris M: Demonstration of viraemia patterns in hemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates. Lancet 336:1022-1025, 1990
Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, Purcell RH: Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135-140, 1992
Rights and permissions
About this article
Cite this article
Quinti, I., Salman, D.E., Monier, M.K. et al. HCV Infection in Egyptian Patients with Acute Hepatitis. Dig Dis Sci 42, 2017–2023 (1997). https://doi.org/10.1023/A:1018897813268
Issue Date:
DOI: https://doi.org/10.1023/A:1018897813268